http://www.cnr.it/ontology/cnr/individuo/prodotto/ID48640
A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts (Articolo in rivista)
- Type
- Label
- A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts (Articolo in rivista) (literal)
- Anno
- 2011-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1002/cmmi.444 (literal)
- Alternative label
Lanzardo, S.; Conti, L.; Brioschi, C.; Bartolomeo, M. P.; Arosio, D.; Belvisi, L.; Manzoni, L.; Maiocchi, A.; Maisano, F.; Forni, G. (2011)
A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts
in Contrast media & molecular imaging
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Lanzardo, S.; Conti, L.; Brioschi, C.; Bartolomeo, M. P.; Arosio, D.; Belvisi, L.; Manzoni, L.; Maiocchi, A.; Maisano, F.; Forni, G. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note
- DOI: 10.1002/cmmi.444 (literal)
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Lanzardo, S.; Conti, L.; Forni, G.; Univ Turin, Ctr Mol Biotechnol, Dept Clin & Biol Sci, I-10126 Turin, Italy.
Brioschi, C.; Bartolomeo, M. P.; Maiocchi, A.; Maisano, F.; Bracco Imaging SpA, CRB, Colleretto Giacosa, Province Of Tur, Italy.
Arosio, D.; Manzoni, L.; CNR - Istituto di Scienze e Tecnologie Molecolari, via Golgi 19, I-20133 Milano, Italy.
Belvisi, L.; Università di Milano, Organ & Ind Chem Dept, Milan, Italy and CISI (literal)
- Titolo
- A new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenografts (literal)
- Abstract
- aV beta 3 Integrins are a widely recognized target for in vivo molecular imaging of pathological conditions such as inflammation, cancer and rheumatoid arthritis. We have evaluated the sensitivity of a new, near-infrared fluorescence (NIRF), RGD cyclic probe (DA364) in noninvasive detection of aV beta 3 integrin-overexpressing tumors. DA364's binding affinity for aV beta 3 integrin was first evaluated in vitro. Human aV beta 3 integrin-positive, U-87 MG glioblastoma cells were then xenografted in nude mice, and DA364 was injected intravenously (i.v.) to evaluate its in vivo distribution, specificity and sensitivity in comparison with a commercially available probe. DA364 bound aV beta 3 integrin on U-87 MG cells with high affinity and specificity, both in vitro and in vivo. This binding specificity was corroborated by the strong inhibition of its tumor uptake induced by nonfluorescent, cyclic-RGD peptides. Ex vivo analysis showed that DA364 accumulated at the tumor site, whereas very low levels were detected in liver and spleen. In conclusion, DA364 allows sensitive and specific detection of transplantable glioblastoma by NIRF imaging, and is thus a promising candidate for the elaboration of imaging and therapeutic probes for aV beta 3 integrin-overexpressing tumors. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Prodotto
- Autore CNR di
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di